Centiva Capital’s Stryker SYK Stock Holding History

Centiva Capital’s Portfolio SYK Stock Details SYK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,500	Closed	-$683K	–	2226
2023 Q3	$683K	Buy	2,500 +1,500	+150%	+$430K	0.02%	810
2023 Q2	$305K	Buy	+1,000	New	+$289K	0.01%	1102

Other funds holding SYK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Centiva Capital's SYK Position: Q2 2025 in Review

Centiva Capital sold out of Stryker (SYK) in Q2 2025, closing a stake of 1,082 shares — an estimated $403K sold.

Centiva Capital first reported a position in SYK in Q4 2019 and held it in 10 quarters. The position peaked at $2.56M in Q1 2024. 2,255 funds tracked by Wall St. Rank hold SYK as of Q2 2025.

Centiva Capital reported no remaining Stryker position as of Q2 2025 after selling out during the quarter.
Centiva Capital sold 1,082 Stryker shares in Q2 2025, an estimated $403K.
Centiva Capital first reported a position in Stryker in Q4 2019 and held it in 10 quarters.
Centiva Capital's Stryker position peaked at $2.56M in Q1 2024.
2,255 funds tracked by Wall St. Rank held Stryker as of Q2 2025.

Based on Centiva Capital's 13F filing for Q2 2025, filed 13 Aug 2025.